Produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation for any investor. Do not rely on it for any investment decision.

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution · NASDAQ Global Select
InsiderStreet
EQUITY FACTSHEET
Generated: 2026-Oct-18 · Market data through: 2026-10-16
Last Close
$86.38
2026-10-16
Market Cap
$9.6B
Volume
1.2M
52-Wk High
$92.18
52-Wk Low
$62.05
Trailing PE
25.0
P/S
0.71
Gross Margin
30.3%
Net Margin
3.0%
ROE
12%
ROIC
6%
Piotroski
6/9
Altman Z
2.8
1-Yr Return
+39.3%
5-Yr Return
+41.0%
Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.
SectorHealthcareIndustryMedical - DistributionExchangeNASDAQMarket Cap$9.6BEmployees25,000 (SEC-filed)CEOFrederick LoweryIPO1995-11-03CountryUS
135 Duryea Road, Melville, NY 11747  ·  Tel 631 843 5500  ·  henryschein.com
INSIDERSTREET SCORE51 / 100Street mean $97.71 (7 analysts, last qtr) — their number, not ours
INSIDER CONSENSUS SIGNALTWO-WAY FLOW$0.7M buys against $8.6M sells / 6 mo
1 Year vs S&P 500 · HSIC +39.3% · S&P 500 +15.9% · spread +23.4pp
95113131149Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26HSICS&P 500
7 Years vs S&P 500 · HSIC +41.0% · S&P 500 +189.9% · spread -148.9pp
601422243062019202020212023202420252026HSICS&P 500
Both charts indexed to 100 at the start of their window and drawn on a single shared scale, so the gap to the benchmark is the gap you see. Adjusted closes throughout.
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
INSIDERSTREET
SCORE
51of 100

Score Breakdown

Profitability29/100
Growth47/100
Momentum76/100
Quality65/100
Earnings Quality82/100
Balance Sheet37/100
Value44/100
Risk (safety)65/100
Overall51.3/100
Each component is a diagnostic reading on its own 0-100 scale. The overall score is computed separately from the underlying financials and is not the average of the rows above — components are not equally weighted and three of them (Momentum, Value, Risk) are derived partly from price rather than from the business.

Peer Comparison — IS Score

SymbolIS Score
ABC
61
CAH
59
GKOS
39
IBRX
22
QGEN
66
PODD
71
HSIC
51

IS Score Trend — quarterly

3541485523 Q123 Q324 Q124 Q325 Q125 Q326 Q1
14 quarters, 23 Q1 to 26 Q2. Peak 54 in 24 Q4, latest 51 — -2 since. Fell in 2 of the last 4 quarters. Dashed line marks 40 on the 0-100 scale.
BUSINESS QUALITY51 / 100IS Score 51.3 / 100 · -2.5 from peak of 54
3541485523 Q123 Q424 Q325 Q226 Q1
Fundamental factor model, quarterly. Measures how the business is doing - not where the price is going.
PRICE STRUCTUREBULLISHTechnical Score 66 / 100 · Power +33 · 17 of 22 indicator votes bullish
13%44%74%105%07-2308-1309-0309-2510-16
Vote share across trend, momentum, volume, volatility and pattern families. Describes where the price is, not where it is going.

Both readings sit above the midpoint — business quality at 51 and price structure at 66 out of 100 — so they are not in conflict. The fundamentals and the tape are saying the same thing, which is the case in which either one alone would have been enough.

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
TriggerWhere it stands nowWhat it would mean
IS Score reaches 55 and holds two consecutive quartersnow 51.3would move us up one band
IS Score stops falling - one quarter higher than the priorlast four: 51 → 46 → 45 → 51the direction matters more than the level
Technical vote share back above 50%now 73%price structure no longer broken
Institutional holder count rises two quarters runningpeak 569 → now 569fewer institutions willing to hold is our clearest warning
We publish these so the view can be shown to be wrong. If none of them move and our reading does, we owe you an explanation.

This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.

Site Convergence Score3 of 4top 4% of 29,420 symbols
Sources Aligned— of 3independent disclosures
Congress (180d)0 buysnone disclosed
Insider Buys (180d)1$0.69M
ETF Funds (30d)504 up / 476 downnet +28 funds
Institutions Added (13F)5managers opening or increasing
Congressional and insider figures are disclosed purchases in the trailing 180 days; ETF figures are COUNTS OF FUNDS whose holding changed in 30 days, not dollars. Coincidence of separate disclosures, not coordination. An absent source means nothing qualifying was disclosed in its window.
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Institutions holding — 12 quarters

5285425575712023 Q32024 Q12024 Q32025 Q12025 Q32026 Q1
Peak 569 · latest 569 (+0 from peak).
QuarterHolders13F sharesValueReported own%Guard
2026 Q2569123.9M$10.3B109.2%ex-outlier 95.4%
2026 Q1564120.3M$8.7B106.1%ex-outlier 92.3%
2025 Q4546121.0M$9.0B106.7%
2025 Q3550127.3M$8.4B112.2%
2025 Q2562135.5M$9.8B119.5%
2025 Q1560128.0M$8.6B112.8%
2024 Q4544128.1M$8.6B112.9%
2024 Q3530130.0M$9.2B114.5%
2024 Q2556126.0M$7.9B111.1%
2024 Q1544126.3M$9.0B111.3%
2023 Q4565126.2M$9.3B111.2%
2023 Q3556122.7M$9.0B108.2%
How to read ownership above 100%. A 13F reports the positions a manager has investment discretion over, and where two or more managers share discretion over the same block, each one reports it. Summed across filers, the total can therefore exceed the shares actually outstanding without anything being wrong. We publish the figure as filed rather than netting it down, and flag separately any quarter where the arithmetic is not merely high but impossible.

Why 2026-06 reads 109.23%. Institutions cannot hold more of a company than exists. The reported 123.9M shares exceed the 113.5M outstanding, and a single filer accounts for the excess: Kohlberg Kravis Roberts & Co. L.P. reports 15,652,032 shares against 15,652,032 the prior quarter, a 1x jump, which alone would be 13.8% of the company. Excluding that filing, ownership is 95.4%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

Why 2026-03 reads 106.07%. Institutions cannot hold more of a company than exists. The reported 120.3M shares exceed the 113.5M outstanding, and a single filer accounts for the excess: Kohlberg Kravis Roberts & Co. L.P. reports 15,652,032 shares against 15,652,032 the prior quarter, a 1x jump, which alone would be 13.8% of the company. Excluding that filing, ownership is 92.3%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.

InsiderRoleDateTypeSharesValuePost-Txn Owned
Albertini AndreaCEO, Global Dist. & Tech.2026-09-08TAX W/H603$0.05M120,088
Albertini AndreaCEO, Global Dist. & Tech.2026-09-08D-Return3,984—116,104
Daniel William Kdirector2026-06-12A-Award2,215—7,641
Bergman Stanley Mother: Former Director2026-05-26GIFT50—253,279
Murphy Kelly AnnSVP & General Counsel2026-05-21—1,479$0.09M0
Murphy Kelly AnnSVP & General Counsel2026-05-21—9,274$0.71M0
Murphy Kelly AnnSVP & General Counsel2026-05-21—2,979$0.26M0
Bergman Stanley Mdirector2026-05-21GIFT50—253,279

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
6-mo decomposition (Form 4)TxnsSharesValueSignal weight
S — Open-market sales10105,911$8.6MCounted
P — Open-market purchases110,000$0.7MCounted
F — Tax withholding1529,164$2.3MNone — compensation
G — Gifts106,625—None

Monthly Net Insider Flow (000 shares)

-140K638K1416K2194K-14002+219403+905+206-509
Net of acquisitions minus dispositions, all Form 4 types.

Signal Summary

SignalTwo-Way Flow
Open-Market Sells$8.6M10 txns / 6 mo
Open-Market Buys$0.7M1 txns / 6 mo
ClusterNone active3+ insiders / 21 days
FiledFilerShares registeredEst. proceeds
2026-08-14Stanley M. Bergman35,257$3.2M
2026-06-30Herring Joseph L28,791$2.4M
2026-06-16Stanley M. Bergman16,933$1.4M
2026-03-19Popeck Thomas C1,355$0.1M
Trailing 12 mo10 filings192,924$16M
FiledFormReporting person% of classShares
2026-04-30SCHEDULE 13GVanguard Capital Management6.36%7.3M sh
2026-03-27SCHEDULE 13G/AThe Vanguard Group—exit/reporting change
2026-03-10SCHEDULE 13D/AKKR Hawaii Aggregator L.P.16.10%18.5M sh
2026-03-10SCHEDULE 13D/AGeorge R. Roberts16.40%18.9M sh
MemberChamberTradeSize bandTradedDisclosed
Michael McCaulHouseSELL$1,001 - $15,0002026-06-182026-07-13
Michael T. McCaulHouseSELL$1,001 - $15,0002026-06-182026-07-13
Michael McCaulHouseSELL$15,001 - $50,0002026-01-092026-02-12
Susan M. CollinsSenateSELL$15,001 - $50,0002022-01-062022-02-17
Susan M. CollinsSenateSELL$15,001 - $50,0002022-01-062022-02-16
Susan Margaret CollinsSenateSELL$15,001 - $50,0002022-01-062022-02-16
House 12-Mo4 trades0 purchases
Senate 12-Mo0 tradesNone purchases
CoverageSTOCK Act filings30-45 day disclosure lag

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
13F Filers (last complete Q)564
13F Shares120M106.1% of shares out
New / Closed75 / 45positions, QoQ
Increased / Reduced181 / 195positions, QoQ
Put/Call (13F)0.50option positions
Free Float82.3%92M sh

2.8 · Largest Reporting 13F Managers

ManagerSharesValue
Assenagon Asset Management S.A.68,079$6M
Ghp Investment Advisors, Inc.53,139$4M
Wealth Enhancement Advisory Servic43,104$3M
Baker Ellis Asset Management Llc42,494$4M
Formuepleje A/S31,439$3M
Salem Investment Counselors Inc30,680$3M
EDGAR 13F holdings as of 2026-09-30; filer values normalized to dollars.

2.9 · Top ETF & Fund Ownership

FundWeightPosition
VITSX0.0%$253M
VTSAX0.0%$253M
VSMPX0.0%$253M
VTI0.0%$253M
VFFSX0.0%$211M
VOO0.0%$211M

13F Filers Holding HSIC — quarterly

52854255757124Q124Q325Q125Q326Q1

Institutional Put/Call — quarterly

0.390.701.011.3224Q124Q325Q125Q326Q1
24%44%64%85%07-2308-1008-2609-1409-30
Daily short-sale volume as % of volume reported in FINRA's short-sale file — a flow measure, not short interest; dashed = 50-day average.
Latest Session57.0%2026-10-15
20-Day Avg59.7%50-day 66.0%
TrendFalling20d vs 50d
By Market CenterQ: 57% · N: 57% · B: 100%latest session
Weekly Notional ($B)
$0.1B$0.1B$0.2B$0.3B06-1507-0607-2708-17

Where HSIC Trades in the Dark

ATS Venue (4-wk)SharesAvg trade
Incr Intelligent Cross Llc1.3M47 sh
Ubsa Ubs Ats1.2M49 sh
Sgmt Sigma X20.7M39 sh
Ebxl Level Ats0.6M25 sh
Mstx Ms Trajectory Cross (Ats-1)0.6M30 sh
Mspl Ms Pool (Ats-4)0.5M166 sh

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Revenue$13.2BGross profit$3.8BCost of revenue$9.3BOperating income$0.8BSG&A$3.1BNet income$0.4BTax$0.1B
Where a dollar of Henry Schein, Inc. revenue goes. All values FY2025 filings, live. Product segmentation not yet parsed for this symbol — revenue shown unsegmented.
SwitchingIntangiblesNetworkCost adv.Scale
HSIC (live moat model)Peer median: ABC · CAH · GKOS · IBRX · QGEN
Component scores from the live moat model. Peer median illustrative.

Moat score 37/100 — None; primary source Efficient Scale.

3.8 · Employees (SEC filings)

18K20K23K25K2018202020222024
OfficerTitle
Andrea AlbertiniChief Executive Officer of Global Distribution & Technology
Mark E. MlotekExecutive Vice President & Chief Strategic Officer
Michael Saul EttingerExecutive Vice President & Chief Operating Officer
Ronald N. SouthSenior Vice President & Chief Financial Officer

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Revenue ($B)
$0B$5B$9B$14B12FY2113FY2212FY2313FY2413FY2514FY26E14FY26E
EPS ($) — GAAP diluted actual, street-basis estimate
$0.00$1.80$3.59$5.394.45FY213.91FY223.16FY233.05FY243.27FY255.39FY26E5.30FY26E
Actual bars are GAAP diluted EPS from the filed income statement; the lighter forward bars are street-basis consensus. The two are different measures and are not comparable quarter to quarter.
Quarterly EPS — Actual vs. Consensus
$0.00$0.55$1.10$1.6625-0525-0825-1126-0226-0526-08NextE
Beats (>2%)5 of 6recent quarters
Avg Surprise+3.5%
Next Report2026-11-03
Income Quality1.65OCF ÷ net income
Beat Rate—%0 of 0 quarters
Current Streak0longest 0
Avg EPS Surprise—%median —%
Surprise Trend—last 4 vs prior 4
PeriodEPS est.EPS actualEPS surpriseRev est. ($M)Rev actual ($M)Rev surprise
Announcement dates to . Consensus as it stood at each report. Revenue surprise shown where both estimate and actual are filed. A beat record is history, not a forecast.
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
$0B$4B$9B$13BFY21FY22FY23FY24FY25RevenueGross profitOperating incomeNet income
Profit Margins (%)
0%10%20%30%29.66.95.0FY2128.97.44.3FY2229.65.83.4FY2329.75.83.1FY2429.15.73.0FY25GrossOperatingNet
YoY Growth Heatmap — Income Lines
YoY growthFY21FY22FY23FY24FY25
Revenue+22.5%+2.0%-2.4%+2.7%+4.0%
Gross profit+30.5%-0.6%+0.1%+3.1%+2.0%
Operating income+50.7%+9.7%-23.9%+2.1%+4.0%
Net income+55.1%-13.8%-22.7%-6.2%+2.1%
$B · FY endsFY21FY22FY23FY24FY25Trend
Revenue12.412.612.312.713.2
Cost of revenue8.79.08.78.99.3
Gross profit3.73.63.73.83.8
R&D expense0.00.00.00.00.0
SG&A expense2.82.72.93.03.1
Operating income0.90.90.70.70.8
EBITDA1.11.00.90.91.0
D&A0.20.20.20.30.3
Pretax income0.90.70.60.50.5
Income tax0.20.20.10.10.1
Net income0.60.50.40.40.4
Diluted EPS ($)4.453.913.163.053.27
Diluted shares (M)142138132128122

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Operating CF$1B
CapEx$0B
Free cash flow$1B
SBC$0B
Buybacks$1B
Net cash change$0B
Operating cash flow$0.71BCash reserves drawn$0.28BFree cash flow$0.57BCapEx$0.14BBuybacks$0.85B

Balance Sheet — Full

$BFY22FY23FY24FY25
Cash & equivalents0.10.20.10.2
ST investments0.00.00.00.0
Receivables (net)1.41.91.51.7
Total current assets4.04.54.04.5
PP&E (net)0.70.80.80.9
Goodwill + intangibles3.54.84.95.2
Total assets8.610.610.211.2
Accounts payable1.01.01.01.2
Short-term debt0.10.40.70.9
Deferred revenue0.00.00.00.0
Total current liabilities2.22.72.83.2
Long-term debt1.01.91.82.6
Total liabilities3.95.45.46.4
Shareholders' equity4.75.24.84.8

Cash Flow Statement — Full

$BFY22FY23FY24FY25
Net income0.60.40.40.4
D&A0.20.20.30.3
Stock-based compensation0.10.00.00.0
Working capital change(0.3)(0.2)0.1(0.0)
Operating cash flow0.60.50.80.7
Capital expenditures(0.1)(0.1)(0.2)(0.1)
Investing cash flow(0.3)(1.1)(0.4)(0.5)
Buybacks(0.5)(0.3)(0.4)(0.9)
Dividends paid0.00.00.00.0
Debt issuance / (repay)0.30.90.20.6
Financing cash flow(0.3)0.7(0.5)(0.1)
Free cash flow0.50.40.70.6
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Balance Sheet Structure ($B)
$0B$4B$7B$11BFY22FY23FY24FY25Total assetsTotal liabilitiesEquity
Cash Generation vs Capex ($B)
$0B$0B$1B$1BFY22FY23FY24FY25Operating CFCapexFree cash flow
Left: what the balance sheet is made of — the gap between the assets bar and the liabilities bar is book equity. Right: whether the capex bar is covered by the operating-cash bar; where it is not, the difference was funded externally and free cash flow goes negative.
RatioFY21FY22FY23FY24FY25TTMTrend
PROFITABILITY
ROE18.4%15.7%11.7%11.1%12.0%12%
ROA7.7%6.3%4.3%3.8%3.7%3.5%
ROIC14.6%14.0%8.8%9.0%8.7%6.5%
Gross margin29.6%28.9%29.6%29.7%29.1%30.3%
Operating margin6.9%7.4%5.8%5.8%5.7%5.7%
Net margin5.0%4.3%3.4%3.1%3.0%3.0%
EBITDA margin8.6%7.7%7.1%7.4%7.6%7.7%
FCF margin5.1%4.0%2.9%5.3%4.3%—
VALUATION
P/E17.4420.1723.7922.2922.6425.0
P/B3.183.152.712.562.783.1
P/S0.880.860.800.690.680.71
P/FCF17.2421.4428.0412.9616.0617.9
EV/EBITDA11.2212.5214.2212.1612.5512.7
EV/Revenue0.970.971.010.900.951.0
Earnings yield5.7%5.0%4.2%4.5%4.4%4.11%
FCF yield5.8%4.7%3.6%7.7%6.2%5.60%
RatioFY21FY22FY23FY24FY25TTMTrend
LEVERAGE & SOLVENCY
Current ratio1.671.791.671.421.381.32
Quick ratio0.860.911.000.780.760.73
Debt / equity0.360.430.750.851.141.21
Debt / assets14.3%17.4%25.9%28.1%32.9%33.5%
Net debt / EBITDA1.031.412.932.923.533.50
Interest coverage31.0917.397.234.924.59—

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
RatioFY21FY22FY23FY24FY25TTMTrend
EFFICIENCY
Asset turnover1.531.481.291.221.231.20
Receivables turnover8.628.747.477.588.427.7
DSO (days)424249484347
DPO (days)434243414144
Cash conversion cycle707886827783
GROWTH (YoY)
Revenue growth22.6%2.0%-2.4%2.7%4.0%—
Net income growth55.1%-13.8%-22.7%-6.2%2.1%—
EPS growth58.4%-10.9%-19.7%-2.4%8.3%—
FCF growth12.3%-19.8%-30.2%90.1%-16.4%—
PER SHARE ($)
EPS (diluted, TTM)4.453.963.183.103.363.55
Book value / share24.4125.3627.9627.0127.4241.63
Revenue / share88.3893.0994.38100.88111.41119.89
FCF / share4.503.722.705.344.744.75
Cash / share0.840.861.310.971.321.38
SHAREHOLDER RETURN & SCORES
Buyback yield3.8%4.7%2.6%4.4%9.4%7.49%
Altman Z-Score4.324.263.183.072.762.8
Piotroski F-Score865646/9
Beneish M-Score-2.51-2.50-2.15-2.84-2.49-2.58
ModelScoreZoneNote
Piotroski F-Score6 / 9Middling
Altman Z-Score2.8Grey zoneGrey
Income quality1.65Cash-backedOCF ÷ net income
Beneish M-Score-2.58Non-manipulatorvs −2.22 threshold
DuPont Decomposition (TTM)Value
Tax burden0.72
Interest burden0.78
Operating margin5.3%
Asset turnover1.22×
Financial leverage3.38×
= ROE12%
Growth Quality (live)Value
Revenue stability0.85
Earnings stability0.69
Earnings persistence0.99
Revenue CAGR 3y2.6%
EPS CAGR 3y0.5%
FCF CAGR 3y0.4%
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Buyback Yield7.49%
Dividend Yield0.00%none paid
Total Shareholder Return7.46%cash yield
SBC / Revenue0.2%dilution pressure
P/E · now 25.017x20x23x26x
P/S · now 0.710.7x0.7x0.8x0.9x
EV/EBITDA · now 12.711x12x13x14x
CompanyMkt capP/EROENet marginRev growthPiotroski1-yr ret
ABC$36.1B13.3104%0.9%+2.9%7/9—
CAH$58.8B34.9-61%0.6%+14.2%8/9+67.3%
GKOS$9.7B-50.7-26%-9.9%+41.5%3/9+93.2%
IBRX$9.7B-9.4123%—+192.9%4/9+262.8%
QGEN$9.5B23.712%19.3%+3.0%8/9-4.2%
PODD$9.8B26.326%11.8%+29.4%9/9—
BIO$9.5B42.53%57.1%+1.4%7/9—
MASI$9.4B125.09%14.1%-14.4%7/9—
1-yr returns computed from adjusted price history; peers without a tracked series show —.
Buy
34 Analysts
Str Sell (0)Sell (3)Hold (14)Buy (17)Str Buy (0)
Mean Target (qtr)$97.717 targets
Target vs. Price+13.1%last-quarter mean
Next Report2026-11-03street $1.36
Consensus estimatesRevenue meanHigh / LowEPS meanHigh / Low# EPS est.
FY2026$13.87B$13.90B / $13.85B$5.39$5.43 / $5.3510
FY2026$13.57B$13.72B / $13.47B$5.30$5.37 / $5.2311
FY2027$14.43B$14.58B / $14.34B$5.99$6.27 / $5.8711

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Street Price Target — Trajectory

WindowAvg Targetvs. Price# Targets
Last Month$92.00+6.5%1
Last Quarter$97.71+13.1%7
Last Year$90.85+5.2%20
All Time$87.13+0.9%30
Rolling mean of published targets vs. last close $86.38. Aggregated from StreetInsider, Benzinga.

Third-Party Composite Rating

B
DCF
4/5
ROE
4/5
ROA
4/5
Debt/Eq
1/5
P/E
2/5
P/B
2/5
Independent quant composite as of 2026-10-16; components scored 1–5 (5 best). Shown for contrast with the InsiderStreet Score — methodologies differ.
HSIC +39.3% vs S&P 500 +15.9% — spread +23.4pp
95113131149Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26HSIC +39%S&P 500 +16%
Sector — XLV +24.2%
97115132149Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26HSICXLV
Peer Set — indexed to 100
49171293415Sep 25Nov 25Jan 26Mar 26May 26Jul 26Aug 26HSIC +39%CAH +67%GKOS +93%IBRX +263%QGEN -4%
All series indexed to 100 at the start of the window, adjusted closes.

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
$67$75$84$933MVol705030RSI 53Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26▮ up▮ downSMA20SMA50BB(20,2)RSI(14)
Candlesticks with SMA 20/50 overlay, Bollinger (20,2σ) band, volume, and Wilder RSI(14) — computed from live daily OHLCV.
$68$76$84$92Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26▮up▮downSMA 20SMA 50SMA 200EMA 9EMA 21·· ST Bull·· ST Bear
Moving AverageValueDistance% DistanceSignal
SMA 20$85.19+1.19+1.40%Above
SMA 50$87.38-1.00-1.14%Below
SMA 200$80.67+5.71+7.08%Above
EMA 9$85.48+0.90+1.05%Above
EMA 21$85.62+0.76+0.89%Above
EMA 50$85.99+0.39+0.45%Above
EMA 200$81.35+5.03+6.18%Above
Series and readings from the nightly technical-indicator history — identical data to the site's ribbon chart. Supertrend segments colored by direction.

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
TECHNICAL VERDICTBULLISHPower Score +3317 of 22 indicator votes bullish

Family Scores (site weights)

Trend 30%56
Momentum 25%91
Volume 20%81
Volatility 10%50
Patterns 15%38
13%44%74%105%07-2308-1309-0309-2510-16
This Week73% bullishof 11 price-based votes
4 Weeks Ago18%+55 pts since
12 Weeks Ago45%+28 pts since
ReadImprovingweek-over-week trajectory
Price vs SMA 20$85.19
Price vs SMA 50$87.38
Price vs SMA 200$80.67
EMA 9/21 Cross85.5/85.6
SMA 50/200Golden
ADX DirectionADX 20
Supertrend$89
Parabolic SAR$80
SMA Slope0.080
RSI52.6
Stochastic K/D86/81
StochRSI K/D94/93
Williams %R-20
CCI133
TSI vs Signal-6.9
CMO5.3
ROC1.77%
OBV SignalAccum
Chaikin MF0.060
MFI49
Force Index0M
Elder Ray Bull2.51
52.6RSI (14)30 oversold · 70 overbought
86.4Stochastic %Kvs %D 81
48.7Money Flowvolume-weighted RSI
20.5ADXtrend strength · <20 weak
20Williams %Rinverted scale
LevelValueLevelValue
Pivot / R1 / R2$86.85 / $87.47 / $87.94S1 / S2$86.38 / $85.76
Bollinger (20,2)$83.21 – $87.18SqueezeON
52-wk range$61.95 – $92.18Off 52-wk high-6.3%
ATR (14)$1.95 (2.3%)Historical vol19.8%

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
+2.5%Jan65%
+0.3%Feb65%
+0.9%Mar67%
+0.2%Apr45%
+1.7%May65%
+0.3%Jun40%
+1.8%Jul60%
-1.6%Aug35%
-0.5%Sep45%
-0.8%Oct30%
+2.1%Nov70%
+0.8%Dec45%
Sample: 20 years — treat short histories as suggestive, not statistical.
Computed from live weekly pricesHSICS&P 500
Weekly volatility (σ, 1y)3.63%1.83%
Best / worst week (1y)+11.4% / -6.5%—
Max drawdown (5y, monthly)-35.3%—
1-week VaR (95%)-5.3%—
Beta (5y)0.811.00
HSIC EQUITY WEATHER (LIVE)CLOUDY · +1
Trend-23
Momentum+29
Volume+41
Volatility-30
Breadth-30
MARKET REGIME (2026-10-16)NEUTRAL
VIX19.99Normal
Dow TheoryConfirmed Bearish
SPY / QQQ TSI7.2 / 4.7trend strength
Sector Strength46/100breadth average
-0.05+0.28+0.62+0.9502-0203-1604-2006-0107-1308-1710-05
Average sentiment of 115 stories, weekly buckets, −1 to +1.
This space intentionally left blank — the next section begins on the following page

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY
Overall+1.0+11.3 vs industry
Trend-23.4-22.4 vs industry
Momentum+29.3+36.8 vs industry
Volume+41.2+26.2 vs industry
ReadingHSICMedical - Distribution
n=156
Healthcare
n=5,272
All US symbols
n=70,435
Overall+1.0-10.3-24.0-20.5
Trend-23.4-1.0-25.6-21.3
Momentum+29.3-7.4-28.5-15.8
Volume+41.2+15.0-25.0-3.8
Trend, momentum and volume are computed per company. Volatility and breadth are market-regime values shared by every symbol in the universe, so they are reported once under Market Regime rather than compared here - a company cannot differ from its sector on a constant.
ExecutiveTotal compStructure
Stanley M. Bergman Chairman and Former Chief$12.0M84% equity+incentive
Mark E. Mlotek Executive Vice President and $3.7M79% equity+incentive
Michael S. Ettinger Executive Vice President$3.4M77% equity+incentive
Andrea Albertini Chief Executive Officer, Gl$3.4M64% equity+incentive
Ronald N. South Senior Vice President, Chief$2.7M75% equity+incentive
Pillar (live disclosure scores)Score
Environmental59
Social61
Governance59
Composite ESG60
Composite ESG Trend
5758595920162019202120232025
Filed8-K contentsItems
2026-10-08Officer/Director Change; Regulation FD; Exhibits5.02,7.01,9.01
2026-09-22Material Agreement; Financial Obligation; Exhibits1.01,2.03,9.01
2026-08-04Earnings Release; Exhibits2.02,9.01
2026-07-30Officer/Director Change; Regulation FD; Exhibits5.02,7.01,9.01
2026-05-22Shareholder Vote; Regulation FD; Exhibits5.07,7.01,9.01
2026-05-05Earnings Release; Exhibits2.02,9.01
2026-02-24Results of Operations and Financial Condition; Financial Statements an2.02,9.01
2026-01-12Departure/Election of Directors; Appointment of Officers; Amendments t5.02,5.03,9.01

Henry Schein, Inc. (HSIC)

Healthcare / Medical - Distribution
InsiderStreet
EQUITY FACTSHEET
Report Date: 2026-Oct-18
NOT INVESTMENT ADVICE — FOR INFORMATIONAL PURPOSES ONLY

Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.

DISCLOSURES. This document is produced by InsiderStreet.ai from live production data. It is not investment advice, not an offer or solicitation to buy or sell any security, and not a recommendation tailored to any person. Data is sourced as of the dates shown and may no longer be current. InsiderStreet.ai is not a registered investment adviser or broker-dealer. Investing involves risk, including loss of principal. Past performance does not guarantee future results. Do not make any investment decision based on this document. © 2026 InsiderStreet.ai — all rights reserved. Redistribution prohibited.
Data domainSourceCoverage for this report
Price & volumemarket_db.historical_prices52 rows
Fundamentalsincome_statements_annual6 rows · 2020 to 2025
Reported vs consensusfact/earnings_calendar24 rows · 2020-11-02 to 2026-08-04
Analyst estimatesdim/forward_estimates3 rows · 2026-12-27 to 2027-12-27
Institutional ownership (13F)holdings_db.institutional_ownership_summary113 rows · 1998 to 2026
Insider transactions (Form 4)edgar/form412 rows · 2026-03-17 to 2026-09-08
Proposed sales (Form 144)edgar/form1441 record
Beneficial ownership (13D/G)edgar/13dg4 rows · 2026-03-10 to 2026-04-30
Short-sale volume (FINRA)edgar/short_volume_daily60 rows · 2026-07-23 to 2026-10-15
Dark pool (ATS, tier 1)edgar/darkpool_weekly12 rows · 2026-06-15 to 2026-08-31
ETF & fund holdingetf_holdings_changelog (30d)1 record
Peer setstock_peers_dynamic8 rows
Industry mediansindustry_medians1 record
Congressional tradescongress_db (House + Senate)1 record
ESGfact/esg_disclosures1 record

Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.

Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.